Apontis Pharma AG (APPH.DE)
EUR 10.05
(0.0%)
EUR 10.05
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -15.1 Million EUR | -366.34% |
| 2022 | 5.66 Million EUR | 239.23% |
| 2021 | 1.67 Million EUR | 374.24% |
| 2020 | -609.42 Thousand EUR | 72.83% |
| 2019 | -2.24 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 715.23 Thousand EUR | 106.86% |
| 2023 Q2 | -5.11 Million EUR | -1811.89% |
| 2023 Q4 | -10.42 Million EUR | -103.89% |
| 2023 FY | -15.1 Million EUR | -366.34% |
| 2022 Q2 | 3.07 Million EUR | -43.57% |
| 2022 FY | 5.66 Million EUR | 239.23% |
| 2022 Q4 | 298.63 Thousand EUR | -90.3% |
| 2021 FY | 1.67 Million EUR | 374.24% |
| 2021 Q4 | 5.45 Million EUR | 253.7% |
| 2021 Q2 | -3.54 Million EUR | 0.0% |
| 2020 FY | -609.42 Thousand EUR | 72.83% |
| 2019 FY | -2.24 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| MPH Health Care AG | 15.7 Million EUR | 196.178% |
| Dermapharm Holding SE | 182.89 Million EUR | 108.256% |
| Evotec SE | -47.5 Million EUR | 68.215% |
| MERCK Kommanditgesellschaft auf Aktien | 3.6 Billion EUR | 100.418% |
| PharmaSGP Holding SE | 40.91 Million EUR | 136.907% |
| SynBiotic SE | -7.58 Million EUR | -99.157% |